Results 21 to 30 of about 252,158 (241)
Investigation of early signs of peripheral artery disease in patients with schizophrenia using toe-brachial index [PDF]
, 2021 INTRODUCTION: Patients with schizophrenia have a reduced life expectancy compared to the general population, and cardiovascular diseases contribute to this.
Hostrup, C. Tranekær +3 more
core +2 more sources
Schizophrenia And Polycystic Ovary Syndrome: A Case Report
European Psychiatry, 2022 Introduction Patients with Polycystic ovary syndrome (PCOS) have increased vulnerability to psychiatric disorders, particularly a tendency to depression and anxiety, as well as schizophrenia.
M. Turki +6 more
doaj +1 more source
Acceptance and Commitment Therapy for Psychosis. What's the evidence? [PDF]
, 2022 publishersversionpublishe
Almeida, C. +4 more
core +1 more source
Imunne system and schyzophrenia
European Psychiatry, 2022 Introduction Schizophrenia affects approximately 1% of the world population, having a devastating impact not only in patients but in all society.
A. Almeida, T. Teixeira, J. Quarenta
doaj +1 more source
CHALLENGE and Face Your Fears: Virtual Reality Treatment for Auditory Hallucinations and Paranoid Ideations [PDF]
, 2022 Background: Many patients suffering from schizophrenia spectrum disorders continue having distressing auditory hallucinations and paranoid ideations despite receiving current treatment. Virtual reality assisted treatment offers the potential of advancing
Christensen, A. +8 more
core +2 more sources
European Psychiatry, 2022 Introduction Suppressor of cytokine signaling (SOCS) proteins are the critical negative regulators of immune responses that exert their effects by inhibiting the Jak/Stat signaling pathway. Objectives To investigate quantitative detection of methylated
H.M. Aytac +3 more
doaj +1 more source
European Psychiatry, 2022 Introduction According to current knowledge inflammation seems to be strongly associated with pathogenesis of schizophrenia. Multiple studies and meta-analyses showed increased levels of inflammatory markers in plasma of schizophrenia patients ...
A. Michalczyk +5 more
doaj +1 more source
European Psychiatry, 2022 Introduction Schizophrenia is a chronic psychiatric illness with periods of remission and relapse. Patients vary in the frequency and severity of relapse, time until relapse and time in remission.
I. Winter +3 more
doaj +1 more source
First-rank symptoms: Past, present and future
European Psychiatry, 2021 Introduction Conceptualising Schneider’s first-rank symptoms (FRS) as a diagnostic test whose performance can be measured in terms of sensitivity and specificity involves some issues that require reflection. The first formal proposal was contained in a
B. Jorge +3 more
doaj +1 more source
Cognitive impairment in treatment-refractory schizophrenia and type i diabetes. A case
European Psychiatry, 2021 Introduction Even when sharing etiologic factors, the incidence of DM-1 is low in patients with schizophrenia. Both diseases can lead to cognitive impairment, but its difficult to define its origin.
L. Soldado Rodriguez +3 more
doaj +1 more source